Rellingen, Germany

Klaus Gutsche


Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 1978-1983

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Klaus Gutsche: Innovator in Pharmaceutical Chemistry

Introduction

Klaus Gutsche is a notable inventor based in Rellingen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with antibacterial properties. With a total of 7 patents, Gutsche's work has had a considerable impact on medical treatments.

Latest Patents

Gutsche's latest patents include innovative compounds such as N-Pyrimidinyl-carbamic acid esters and their preparation. These compounds, particularly the 2-Carbamic acid esters of 2,4-diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimidine (trimethoprim), serve as pro-drugs that enhance the antibacterial action of sulfonamides. Another significant patent involves tertiary imidazolyl alcohols, which are directed towards treating generalized and local infections caused by fungi or yeasts. This invention includes a method for administering these compounds in suitable pharmaceutical preparations.

Career Highlights

Throughout his career, Klaus Gutsche has worked with prominent companies such as BASF Aktiengesellschaft and Nordmark-Werke GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical chemistry.

Collaborations

Gutsche has collaborated with notable colleagues, including Peter Scharwaechter and Wilhelm Kohlmann. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Klaus Gutsche's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and antibacterial compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…